Tear and serum soluble leukocyte activation markers in conjunctival allergic diseases.

[1]  C. Caruso,et al.  Allergic rhinitis to grass pollen: measurement of inflammatory mediators of mast cell and eosinophils in native nasal fluid lavage and in serum out of and during pollen season. , 1997, The Journal of allergy and clinical immunology.

[2]  M. Plebani,et al.  Effect of lodoxamide and disodium cromoglycate on tear eosinophil cationic protein in vernal keratoconjunctivitis , 1997, The British journal of ophthalmology.

[3]  S. Holgate,et al.  Phenotypic characterization of T cells infiltrating the conjunctiva in chronic allergic eye disease. , 1996, The Journal of allergy and clinical immunology.

[4]  P. Montan,et al.  Eosinophil cationic protein in tears in allergic conjunctivitis. , 1996, The British journal of ophthalmology.

[5]  A. Leonardi,et al.  Tear Histamine and Histaminase during the Early (Epr) and Late (Lpr) Phases of the Allergic Reaction and the Effects of Lodoxamide , 1996, European journal of ophthalmology.

[6]  M. Abelson,et al.  Histaminase activity in patients with vernal keratoconjunctivitis. , 1995, Ophthalmology.

[7]  M. Plebani,et al.  Eosinophil cationic protein in tears of normal subjects and patients affected by vernal keratoconjunctivitis , 1995, Allergy.

[8]  A. Lambiase,et al.  Increased serum levels of eosinophil cationic protein and eosinophil-derived neurotoxin (protein X) in vernal keratoconjunctivitis. , 1994, Ophthalmology.

[9]  A. Aldave,et al.  The eye and the eosinophil. , 1994, Survey of ophthalmology.

[10]  M. Matsuzaki,et al.  Serum Levels of Soluble IL-2R, IL-4, and Soluble FcɛRII in Adult Bronchial Asthma , 1994 .

[11]  P. Venge,et al.  Soluble markers of allergic inflammation , 1994, Allergy.

[12]  S. Bonini,et al.  Markers of eosinophilic inflammation in allergic diseases , 1993, Allergy.

[13]  M. Battista,et al.  Antigen sensitivity evaluated by tear-specific and serum-specific IgE, skin tests, and conjunctival and nasal provocation tests in patients with ocular allergic disease , 1993, Eye.

[14]  J. Bousquet,et al.  Indirect evidence of nasal inflammation assessed by titration of inflammatory mediators and enumeration of cells in nasal secretions of patients with chronic rhinitis. , 1992, The Journal of allergy and clinical immunology.

[15]  J. Bousquet,et al.  Indirect evidence of bronchial inflammation assessed by titration of inflammatory mediators in BAL fluid of patients with asthma. , 1991, The Journal of allergy and clinical immunology.

[16]  P. Venge,et al.  Radioimmunoassay of human eosinophil cationic protein (ECP) by an improved method. Establishment of normal levels in serum and turnover in vivo , 1991, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[17]  W. Chambers,et al.  Conjunctival allergen challenge. A clinical approach to studying allergic conjunctivitis. , 1990, Archives of ophthalmology.

[18]  G. Gleich,et al.  Conjunctival deposition of eosinophil granule major basic protein in vernal keratoconjunctivitis and contact lens-associated giant papillary conjunctivitis. , 1989, American journal of ophthalmology.

[19]  A. Vecchione,et al.  Inflammatory changes in conjunctival scrapings after allergen provocation in humans. , 1988, The Journal of allergy and clinical immunology.

[20]  P. Venge,et al.  Eosinophil cationic protein and myeloperoxidase in nasal secretion as markers of inflammation in allergic rhinitis , 1987, Allergy.

[21]  M. Allansmith.  The eye and immunology , 1982 .

[22]  G. Gleich,et al.  Eosinophil granule major basic protein and Charcot-Leyden crystal protein in human tears. , 1981, American journal of ophthalmology.

[23]  M. Abelson,et al.  Tear histamine levels in vernal conjunctivitis and other ocular inflammations. , 1980, Ophthalmology.